55 minutes
2018 witnessed the first FDA-approved prescription-only phone app for treating substance abuse disorder. Wearables and other patient test data are now integrated directly to the physician or to the clinical trial sponsor. This panel will feature a discussion of whether and how digital health is improving patient care, whether it’s reducing costs, and what needs to be done for it to reach its full potential?

Speakers

Chrissy Farr - Health and Tech Reporter, CNBC
Grace Colon - President & CEO, InCarda Therapeutics, Inc.
Lesley Solomon - Senior VP & Chief Innovation Officer, Dana-Farber
Luba Greenwood - Managing Partner, Binney Street Capital, CEO, Kojin Therapeutics Senior Lecturer, Harvard University
Raolat Abdulai - Clinical Research Director, Sanofi
Yuri Maricich - CMO & Head of Clinical Development, Pear Therapeutics